Future Science Group (FSG) has launched Future Medicine AI, a new open access, peer-reviewed journal committed to advancing the application of artificial intelligence (AI) in medicine.
“We have reached a point where the pace of digital innovation is seemingly overwhelming. Digitization has begun to sculpt almost every area of society, transforming everything from judicial organizations to healthcare systems. As AI reshapes medicine, Future Medicine AI will be positioned uniquely as a central hub for the communication and dissemination of the latest practice-changing research and high-quality industry insights, building a forward-thinking community of allied researchers, biomedical innovators and allied health practitioners, in a responsible and ethical way,” commented Emma Hall, Commissioning Editor.
It is essential to build digital healthcare technologies upon a foundation encompassing safety and responsibility, and as such, Future Medicine AI aims to cover these challenges and ethical issues to provide a critically reliable source of information for health regulators and policymakers.
Key topics covered by Future Medicine AI include:
- Virtual reality
- Precision medicine
- Ethics and regulation
- Medical imaging and biomedical diagnostics
- Multi-omics research
- Drug discovery and development
- Next-generation clinical trials
- Health management/optimization
- Real world evidence
Future Medicine AI will be guided by a global panel of experts who bring a wealth of experience and expertise in medical AI and digital transformation. Editorial Board member Danny Ruta, Guy’s and St Thomas’ NHS Foundation Trust (London, UK) stated: “Medicine is experiencing a ‘Cambrian explosion’ in its evolution, the likes of which we have never seen in human history, driven by AI, along with advances in robotics, multi-omics and the application of systems science.”
“The pace of change is accelerating at an exponential rate so that new medical innovations are appearing every month. Our traditional evidence-based paradigm is struggling to keep up. The launch of Future Medicine AI is therefore welcome and very timely. It will provide an invaluable contribution to the publication of new methodologies and approaches to the validation of AI in healthcare, and to building a real-world evidence base that will accelerate the deployment of cost-effective AI solutions in routine clinical practice.”
Future Medicine AI considers contributions of a wide range of articles, including original research, reviews and opinion pieces, and is waiving fees during this launch phase. Unsolicited articles are also welcomed.
To submit an article, or for further information, contact the Commissioning Editor Emma Hall: e.hall@future-science-group.com.
